Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions
- Acute Lymphoblastic Leukemia (ALL)
Interventions
- DRUG: Carfilzomib
- DRUG: Dexamethasone
- DRUG: Mitoxantrone
- DRUG: PEG-asparaginase
- DRUG: Vincristine
- DRUG: Intrathecal (IT) Methotrexate
- DRUG: Intrathecal Triple Therapy (Intrathecal Cytarabine, Hydrocortisone, and Methotrexate)
- DRUG: 6-Mercaptopurine
- DRUG: Cyclophosphamide
- DRUG: Cytarabine
- DRUG: Daunorubicin
Sponsor
Amgen
Collaborators
- [object Object]
- [object Object]